-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE 250Dearborn, MI 48124
02864
Test Results
Test Description
Clinical Recommendations
Disclaimers
COV-13C25 Rapid Response COVID-19 IgG/IgM Test
IgG NEGATIVE
IgM NEGATIVE
Specimen Type serum
COV-13C25 Rapid Response COVID-19 IgG/IgM TestDeveloped by BTNX Inc., the COV-13C25 Rapid Response™ COVID-19 IgG/IgM Test Cassette is an in vitro immunoassay for the direct and qualitativedetection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma as an aid in the diagnosis of COVID-19.
Please discuss these results with your physician.
COV-13C25 Rapid Response COVID-19 IgG/IgM TestThe test has not been reviewed by the FDA. Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with thevirus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals. Results from antibody testing should not beused as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status. Positive results may be due to past or present infection withnon-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
Positive test results (IgG/IgM antibodies present) do not guarantee immunity to reinfection.Positive test results (IgG/IgM antibodies present) do not guarantee a patient is no longer an active carrier of the disease.Antibody testing should be always be used in conjunction with laboratory testing methods to diagnose active infections.Tests must be administered and interpreted by healthcare professionals, subject to the governing regulatory body overseeing diagnostic testing in the region ofuse.
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No. 49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751 Park Central Drive, Suite 200 | Richmond, VA 23227 | www.StageZeroLifeSciences.comPage 1
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE 250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No. 49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751 Park Central Drive, Suite 200 | Richmond, VA 23227 | www.StageZeroLifeSciences.comPage 2
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE 250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No. 49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751 Park Central Drive, Suite 200 | Richmond, VA 23227 | www.StageZeroLifeSciences.comPage 3
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE 250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No. 49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751 Park Central Drive, Suite 200 | Richmond, VA 23227 | www.StageZeroLifeSciences.comPage 4
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE 250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No. 49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751 Park Central Drive, Suite 200 | Richmond, VA 23227 | www.StageZeroLifeSciences.comPage 5
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE 250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No. 49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751 Park Central Drive, Suite 200 | Richmond, VA 23227 | www.StageZeroLifeSciences.comPage 6
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE 250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No. 49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751 Park Central Drive, Suite 200 | Richmond, VA 23227 | www.StageZeroLifeSciences.comPage 7
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
![1.1 A brief overview of Fiber Optic Sensorsshodhganga.inflibnet.ac.in/bitstream/10603/48124/8/08_chapter 1.pdf · SC/PC [figure 1.5] connectors in our experiments. FC connectors feature](https://cdn.vdocument.in/doc/165x107/60030c38f222ad7bd110a9ad/11-a-brief-overview-of-fiber-optic-1pdf-scpc-figure-15-connectors-in-our.jpg)